Femoropopliteal artery stent placement: Evaluation of long-term success

Radiology

Volumn 205, Issue 2, 1997, Pages 375-383

  Strecker, Ernst Peter K ^a   Boos, Irene B L ^a   Göttmann, Dieter ^a  

^a Department of Radiology   (Germany)

Author keywords

Arteries, extremities; Arteries, grafts and prostheses; Arteries, stenosis or obstruction; Arteries, transluminal angioplasty

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMITTENT CLAUDICATION; INTERVENTIONAL RADIOLOGY; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; STENT; TREATMENT OUTCOME;

EID: 0030664741     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.205.2.9356617     Document Type: Article

References (36)

1. Alexander K, Brunner U, Ehringer H. Krankheiten der gefässe. In: Siegenthaler W, Kaufmann W, Hornbostel H, Waller HD, eds. Lehrbuch der inneren medizin. Stuttgart, Germany: Verlag, 1992; 184-185.
2. Strecker EP, Liermann D, Barth KH, et al. Expandable tubular stents for the treatment of arterial occlusive diseases: experimental and clinical results - work in progress. Radiology 1990; 175:97-102.
3. Strecker EP, Kuhn FP, Liermann D, et al. Strecker flexible tantalum stent. In: Kim D, Orron DE, eds. Peripheral vascular imaging and intervention. St Louis, Mo: Mosby-Year Book, 1992; 541-552.
4. Rutherford RB, Becker GJ. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral artery disease. JVIR 1991; 2:169-174.
5. Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology. Guidelines for percutaneous transluminal angioplasty. Radiology 1990; 177:619-626.
6. Sachs L. Angewandte statistik. Berlin, Germany: Springer-Verlag, 1992; 269.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
8. Peto R, Peto J. Asymptomatically efficient rank invariant procedures. J R Stat Soc 1972; 135:185-207.
9. Bishop YMM, Fienberg SE, Holland PW. Discrete multivariate analysis. Cambridge, Mass: MIT Press, 1975.
10. Matsi PJ, Manninen HI, Vanninen RL, et al. Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3-year follow-up. Radiology 1994; 191:727-733.
11. Johnston KW, Rae M, Hogg-Johnston SA, et al. Five-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg 1987; 206:403-412.
12. Jeans WD, Armstrong S, Cole SEA, Horrocks M, Baird RN. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia. Radiology 1990; 177:559-564.
13. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1992; 183:767-771.
14. Strunk H, Clouse M, Stokes K, Thelen M. Früh-und spätergebnisse der perkutanen transluminalen angioplastie (PTA) beim diabetiker. ROFO 1991; 154:315-320.
15. Henry M, Amor M, Ethevenot G, et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4-year follow-up. Radiology 1995; 1967:167-174.
16. Thornton M, Grüntzig A, Hollman J. Coumadin and aspirin in the prevention of recurrence rate after successful coronary angioplasty. Circulation 1984; 69:721-727.
17. Liermann D, Strecker EP, Peters J. The Strecker stent: indications and results in iliac and femoropopliteal arteries. Cardiovasc Intervent Radiol 1992; 15:298-305.
18. Rousseau H, Raillat C, Joffre F, et al. Treatment of femoropopliteal stenoses by means of self-expandable endoprostheses: mid-term results. Radiology 1989; 172:961-964.
19. Sapoval MR, Long AL, Raynaud AC, Beyssen BM, Fiessinger JN, Gaux JC. Femoropopliteal stent placement: long-term results. Radiology 1992; 184:833-539.
20. Zollikofer CL, Antonucci F, Pfyffer M, et al. Arterial stent placement with use of the Wallstent: midterm results of clinical experience. Radiology 1991; 179:449-456.
21. Cwikiel W, Harnek J, Zoucas E, Stenram U. Comparison of effects of the self-expandable nitinol Strecker stent vs angioplasty on the normal artery: an experimental study in pigs. Cardiovasc Intervent Radiol 1995; 18(suppl):90.
22. Richter GM, Roeren TK, Simon C. First report on long-term results of the randomized European femoral stent versus angioplasty trial (abstr). JVIR 1996; 7:196.
23. Shapiro MJ, Levin DC. Percutaneous femoropopliteal graft placement: is this the next step? Radiology 1993; 187:618-619.
24. Barth KH, Virmani R, Froelich J, et al. Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents, and Wallstents in canine iliac and femoral arteries. Circulation 1996; 93:2161-2169.
25. Schürmann K, Vorwerk D, Kulisch A, et al. Neointimal hyperplasia in low-profile nitinol stents, Palmaz stents, and Wallstents: a comparative experimental study. Cardiovasc Intervent Radiol 1996; 19:248-254.
26. Blum U, Flügel P, Ebert S, et al. Stent-grafting for stenotic/occlusive lesions of femoropopliteal arteries. Presented at the 38th Annual World Congress of the International College of Angiology, Cologne, Germany, 1996.
27. Link J, Müller-Hülsbeck S, Brossmann J, Schwarzenberg H, Steffens JC, Heller M. Ummantelte stents bei oberschenkelarterienverschlüssen: ein erfahrungsbericht nach 2-jähriger anwendung (abstr). ROFO 1996; 164:107.
28. Henry M, Amor M, Cragg A, et al. Occlusive and aneurysmal peripheral arterial disease: assessment of a stent-graft system. Radiology 1996; 201:717-724.
29. Strecker EP, Gabelmann A. Coated stents for the prevention of intimal hyperplasia after stent implantation (abstr). Cardiovasc Intervent Radiol 1996; 19(suppl):81.
30. Zeitler E. Experience with the Cragg Endopro stent in the superficial femoral artery (abstr). Cardiovasc Intervent Radiol 1994; 17(suppl):558.
31. Henry M. Les endoprothèses au niveau des artères fémorales et poplitées. Actual Vasc Int 1996; 36:6-14.
32. Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334:1084-1089.
33. Karrillon GJ, Morice MC, Benveniste E, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day clinical outcome of the French multicenter registry. Circulation 1996; 94:1519-1527.
34. Strecker EP, Göttmann D, Vetter S, Boos I. Low molecular weight heparin (reviparin) for the prevention of restenosis after femoropopliteal stent implantation (abstr). Cardiovasc Intervent Radiol 1996; 19(suppl):107.
35. Liermann D, Herrmann G, Schopohl B, et al. Endovascular afterloading with 192 iridium HDR in the treatment of recurrent intimai hyperplasia in stented peripheral arteries. In: Liermann D, ed. Stents: state of the art and future developments. Morin Heights, Quebec, Canada: Polyscience, 1995; 299-314.
36. Strecker EP, Gabelmann A. Prevention of intimai hyperplasia after stent implantation by drug releasing stents: an experimental study (abstr). Cardiovasc Intervent Radiol 1995; 18(suppl):103.